- Company
- Translated with AI
Rentschler Biopharma and Vetter present Xpert Alliance – a joint visualization of their successful strategic collaboration
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMO), present Xpert Alliance, a joint visualization of their strategic collaboration. This reflects the lived and successful alliance that offers effective solutions for the changing and growing needs of customers in the field of complex biopharmaceuticals.
The goal of the alliance initiated in mid-2020 is to create long-term added value through close coordination and harmonization of production processes, enabling faster and simpler product supply for patients worldwide. Together, the two CDMOs have expanded their service offerings by providing complementary services and expertise along the value chain. First joint customer projects are underway. From the beginning, the two independent companies have worked closely together to advance this significant alliance. The joint appearance to increase visibility marks another important step in the strategic collaboration.
"It is exciting to see how our alliance is continuously developing and taking shape," says Dr. Frank Mathias, CEO of Rentschler Biopharma. "Vetter and we set ambitious goals for our collaboration and are convinced that our customers can greatly benefit from the complementary services and seamless interaction. Above all, our overarching goal is to provide patients with severe or rare diseases with vital medications."
Vetter Managing Director Peter Sölkner emphasizes: "Within the framework of our strategic alliance, we can develop and implement suitable solutions for our customers from the early development phase of new drugs to market supply. We are very satisfied with the progress we have achieved together so far and look forward to continuing to add value through our collaboration."
The name Xpert Alliance embodies the essence of this strategic partnership, with the slogan – "from substance to product to patient" – outlining the scope of the offering. The joint appearance of Rentschler Biopharma and Vetter is visually represented by two shades of blue in the "X," each corresponding to the corporate colors of the two companies. At the same time, by mentioning both company names, the companies maintain their individuality.
Rentschler Biopharma SE
88471 Laupheim
Germany








